Tech Company Financing Transactions
Good Therapeutics Funding Round
Good Therapeutics closed a $11 million Series A funding round on 5/25/2020. Investors included 3x5 Partners, Codon Capital and Digitalis Ventures.
Transaction Overview
Company Name
Announced On
5/25/2020
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
454 N 34th St.
Seattle, WA 98103
USA
Seattle, WA 98103
USA
Phone
Website
Email Address
Overview
Good Therapeutics is a biotechnology company based in Seattle, Washington. We are developing context-dependent protein drugs that sense biomarkers and respond with a therapeutic activity. Our goal is to make safer, more effective drugs that act only when and where they are needed, limiting systemic toxicity without reducing therapeutic efficacy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Mulligan
Browse more venture capital transactions:
Prev: 5/25/2020: Chief venture capital transaction
Next: 5/26/2020: Curu venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs